Rubio DA, Serrano Mvt, Wang Ehm
Department of Orthopedics, Philippine General Hospital, Manila, Philippines.
Malays Orthop J. 2013 Nov;7(3):1-5. doi: 10.5704/MOJ.1311.007.
At the Philippine General Hospital, tumour endoprostheses have become an option for reconstruction after limb saving surgery for primary bone tumors. We performed a retrospective review of patients with primary bone tumors of the distal femur who underwent tumor excision and reconstruction using tumor endoprostheses. Outcome measures included prosthetic survival, functional outcome and complications. Twenty-two patients were evaluated; 14 males and 8 females, with a mean age of 18 years and a mean follow-up of 56 months. The overall 2-year endoprosthetic survival rate was 86%. Mean MSTS was 23/30. There were a total of 6 revisions. Failure modes included 3 infections, 3 aseptic loosening, 4 structural failures, 2 soft tissue failures and 3 tumor progression. Our early results show that tumor endoprosthesis reconstruction is an acceptable option for patients with primary bone tumor of the distal femur. Survival rates, failure modes and functional outcomes are comparable to other reported studies.
Supracondylar humerus, K-wire fixation, day care procedure.
在菲律宾总医院,肿瘤假体已成为原发性骨肿瘤保肢手术后重建的一种选择。我们对接受肿瘤切除并使用肿瘤假体进行重建的股骨远端原发性骨肿瘤患者进行了回顾性研究。观察指标包括假体生存率、功能结果和并发症。对22例患者进行了评估;其中男性14例,女性8例,平均年龄18岁,平均随访56个月。总体2年假体生存率为86%。平均MSTS评分为23/30。共进行了6次翻修。失败模式包括3例感染、3例无菌性松动、4例结构失效、2例软组织失效和3例肿瘤进展。我们的早期结果表明,肿瘤假体重建对于股骨远端原发性骨肿瘤患者是一种可接受的选择。生存率、失败模式和功能结果与其他报道的研究相当。
肱骨髁上,克氏针固定,日间手术程序。